Showing results (191-200 of 236) with videos related to
Sort By:
Pageof 24
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2022
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysisHannah Hussey, Mary-Ann Davies, Alexa Heekes, et al.Genes|March 29, 2023
Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022Abay Sisay, Derek Tshiabuila, Stephanie van Wyk, et al.Viruses|September 23, 2022
SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the PandemicWael H Roshdy, Mohamed K Khalifa, James Emmanuel San, et al.BMJ Global Health|October 8, 2020
Lockdown measures in response to COVID-19 in nine sub-Saharan African countriesNajmul Haider, Abdinasir Yusuf Osman, Audrey Gadzekpo, et al.Cell|September 19, 2021
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineagesDarren P Martin, Steven Weaver, Houriiyah Tegally, et al.The Lancet. Microbe|July 27, 2025
Identifying genomic surveillance gaps in Africa for the global public health response to West Nile virus: a systematic reviewMonika Moir, Nikita Sitharam, Laura Marije Hofstra, et al.Virus Evolution|December 25, 2024
Emergence of Omicron FN.1 a descendent of BQ.1.1 in BotswanaWonderful T Choga, Emanuele Gustani-Buss, Houriiyah Tegally, et al.PLOS Global Public Health|March 24, 2023
Genomic epidemiology of SARS-CoV-2 during the first four waves in MozambiqueNalia Ismael, Stephanie van Wyk, Houriiyah Tegally, et al.Wellcome Open Research|October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.Cell Host & Microbe|February 5, 2022
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escapeSandile Cele, Farina Karim, Gila Lustig, et al.Pageof 24